- Home
- MPLX vs A Comparison
MPLX vs A Comparison
Compare MPLX & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPLX
- A
- Stock Information
- Founded
- MPLX 2012
- A 1999
- Country
- MPLX United States
- A United States
- Employees
- MPLX N/A
- A N/A
- Industry
- MPLX Oil & Gas Production
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- MPLX Energy
- A Industrials
- Exchange
- MPLX Nasdaq
- A Nasdaq
- Market Cap
- MPLX 48.2B
- A 39.3B
- IPO Year
- MPLX 2012
- A 1999
- Fundamental
- Price
- MPLX $51.16
- A $147.36
- Analyst Decision
- MPLX Buy
- A Buy
- Analyst Count
- MPLX 11
- A 15
- Target Price
- MPLX $49.09
- A $141.93
- AVG Volume (30 Days)
- MPLX 1.6M
- A 1.6M
- Earning Date
- MPLX 02-04-2025
- A 02-25-2025
- Dividend Yield
- MPLX 7.48%
- A 0.65%
- EPS Growth
- MPLX 21.97
- A 5.73
- EPS
- MPLX 4.24
- A 4.43
- Revenue
- MPLX $11,043,000,000.00
- A $6,510,000,000.00
- Revenue This Year
- MPLX $14.01
- A $7.14
- Revenue Next Year
- MPLX $4.97
- A $6.37
- P/E Ratio
- MPLX $12.07
- A $33.26
- Revenue Growth
- MPLX 6.20
- A N/A
- 52 Week Low
- MPLX $36.94
- A $124.16
- 52 Week High
- MPLX $51.94
- A $155.35
- Technical
- Relative Strength Index (RSI)
- MPLX 69.02
- A 71.83
- Support Level
- MPLX $50.00
- A $138.68
- Resistance Level
- MPLX $49.45
- A $146.50
- Average True Range (ATR)
- MPLX 0.82
- A 3.83
- MACD
- MPLX 0.31
- A 1.20
- Stochastic Oscillator
- MPLX 98.03
- A 92.99
About MPLX MPLX LP
MPLX is a partnership that owns both pipelines and gathering and processing assets with extensive holdings in the Appalachian region. The asset base is made up of pipeline assets dropped down from Marathon Petroleum, its sponsor, and gathering and processing assets from MarkWest, which it acquired in 2015. MPLX also acquired Andeavor Logistics in 2019.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.